Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
The objective of this study is to evaluate the efficacy and safety of Velcade plus dexamethasone used as induction chemotherapy prior to autologous transplantation.
Multiple Myeloma
DRUG: Dexamethasone|DRUG: velcade
Complete remission after 4 cycles:|disappearance of serum and/or urine M-component (confirmed by immunofixation)|< 5% plasma cells in the bone marrow resolution of all extra-osseous plasmacytomas|no evidence of bone progression
The objective of this study is to evaluate the efficacy and safety of Velcade plus dexamethasone used as induction chemotherapy prior to autologous transplantation.